The Future of Stock Picking

Tafarma still has a healthy weight to technology, those mega cap names that typically can weather economic cycles and sustain consistent revenue streams. We've also added back in some energy, some mining, and then in healthcare, we're more inclined to go into medical devices and services than we are in Tafarma. Does it surprise you that Europe has outperformed the US and almost everywhere this year? "It is surprising"